This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Vanderbilt University, Cogent Biosciences, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Cori A Malinky: Innovator in FGFR Inhibition
Introduction
Cori A Malinky is a notable inventor based in Boulder, CO. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for FGFR inhibition. His work is essential in advancing treatments for various diseases.
Latest Patents
Cori A Malinky holds 1 patent related to his innovative work. His patent, titled "Compounds for FGFR inhibition," describes a compound with a specific structure, including stereoisomers, salts, or tautomers. The patent also details pharmaceutical compositions comprising these compounds and their applications in treating diseases.
Career Highlights
Cori A Malinky is associated with Cogent Biosciences, Inc., where he continues to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in FGFR inhibition has positioned him as a key player in the field.
Collaborations
Cori has collaborated with notable colleagues, including Jay Bradford Fell and John E Robinson. Their combined efforts enhance the research and development initiatives at Cogent Biosciences, Inc.
Conclusion
Cori A Malinky's work in FGFR inhibition exemplifies the impact of innovative research in pharmaceuticals. His contributions are paving the way for new treatment options and improving patient outcomes.